These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29261014)

  • 21. Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1.
    Shen Y; Ward NC; Hodgson JM; Puddey IB; Wang Y; Zhang D; Maghzal GJ; Stocker R; Croft KD
    Free Radic Biol Med; 2013 Dec; 65():908-915. PubMed ID: 24017971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endothelin: From discovery to pharmacotherapeutic innovations].
    Richard V
    Presse Med; 2014; 43(7-8):742-55. PubMed ID: 24797866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation of endothelium-dependent relaxation in atherosclerotic mice with endothelium-restricted endothelin-1 overexpression.
    Mian MO; Idris-Khodja N; Li MW; Leibowitz A; Paradis P; Rautureau Y; Schiffrin EL
    J Pharmacol Exp Ther; 2013 Oct; 347(1):30-7. PubMed ID: 23902937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macitentan: first global approval.
    Patel T; McKeage K
    Drugs; 2014 Jan; 74(1):127-33. PubMed ID: 24297706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of antagonist selectivity in endothelin receptors.
    Hou J; Liu S; Zhang X; Tu G; Wu L; Zhang Y; Yang H; Li X; Liu J; Jiang L; Tan Q; Bai F; Liu Z; Miao C; Hua T; Luo Z
    Cell Discov; 2024 Jul; 10(1):79. PubMed ID: 39075075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
    Juergens UR; Racké K; Uen S; Haag S; Lamyel F; Stöber M; Gillissen A; Novak N; Vetter H
    Pulm Pharmacol Ther; 2008; 21(3):533-9. PubMed ID: 18295521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of the clinical functional and hemodynamic profile of patients with pulmonary arterial hypertension with initial monotherapy with endothelin receptor antagonists: bosentan vs. macitentan].
    Martynyuk TV; Aleevskaya AM
    Kardiologiia; 2020 Aug; 60(7):28-35. PubMed ID: 33155938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macitentan (Opsumit) for the treatment of pulmonary arterial hypertension.
    Clarke M; Walter C; Agarwal R; Kanwar M; Benza RL
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):415-21. PubMed ID: 24851934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience.
    Belge C; Delcroix M
    Ther Adv Respir Dis; 2019; 13():1753466618823440. PubMed ID: 30736726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macitentan for the treatment of pulmonary arterial hypertension.
    Hong IS; Coe HV; Catanzaro LM
    Ann Pharmacother; 2014 Apr; 48(4):538-47. PubMed ID: 24458948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertension.
    Steriade A; Seferian A; Jaïs X; Savale L; Jutant EM; Parent F; Sitbon O; Humbert M; Simonneau G; Montani D
    Ther Adv Respir Dis; 2014 Jun; 8(3):84-92. PubMed ID: 24728960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelin receptor antagonists.
    Motte S; McEntee K; Naeije R
    Pharmacol Ther; 2006 Jun; 110(3):386-414. PubMed ID: 16219361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension.
    Martynyuk TV; Nakonechnikov SN; Chazova IY
    Ter Arkh; 2018 Apr; 90(4):72-80. PubMed ID: 30701878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
    Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
    J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension.
    Kuc RE; Carlebur M; Maguire JJ; Yang P; Long L; Toshner M; Morrell NW; Davenport AP
    Life Sci; 2014 Nov; 118(2):391-6. PubMed ID: 24582810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury.
    Kirkby NS; Duthie KM; Miller E; Kotelevtsev YV; Bagnall AJ; Webb DJ; Hadoke PW
    Cardiovasc Res; 2012 Jul; 95(1):19-28. PubMed ID: 22467315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertension.
    Iglarz M; Bossu A; Wanner D; Bortolamiol C; Rey M; Hess P; Clozel M
    Life Sci; 2014 Nov; 118(2):333-9. PubMed ID: 24582812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells.
    Gatfield J; Mueller Grandjean C; Sasse T; Clozel M; Nayler O
    PLoS One; 2012; 7(10):e47662. PubMed ID: 23077657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.